Thyroid Disorders in the Context of the COVID-19 Pandemic - Summary - MDSpire

Thyroid Disorders in the Context of the COVID-19 Pandemic

  • By

  • Majd Irsheid

  • Nitzan Burrack

  • Merav Fraenkel

  • Eli Hershkovitz

  • Uri Yoel

  • April 22, 2026

  • 0 min

Share

Objective:

To examine the incidence patterns of Hashimoto’s Thyroiditis (HT), Graves’ Disease (GD), and Subacute Thyroiditis (SAT) during the COVID-19 pandemic compared to the pre-pandemic period, highlighting the significance of these disorders in the context of autoimmune responses.

Key Findings:
  • GD showed a non-significant upward trend in incidence (IRR 1.66, p=0.054), indicating a potential increase that warrants further investigation.
Interpretation:

The COVID-19 pandemic was associated with a significant increase in HT incidence and a decrease in SAT, indicating a heterogeneous impact of the pandemic on different thyroid disorders, which may have implications for patient management.

Limitations:
  • Findings are based on a single health service organization, which may limit generalizability and affect the robustness of conclusions drawn.
  • Potential confounding factors not fully accounted for in the analysis may influence the observed incidence rates.
Conclusion:

The study highlights the need for further investigation into the relationship between COVID-19 and thyroid disorders, particularly regarding the mechanisms behind the observed changes in incidence and potential clinical implications.

Original Source(s)

Related Content